Work

Abstract B112: Obtusaquinone is a cysteine-modifying compound that targets Keap1 for degradation

Year: 2019

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-19-b112

Authors: Cintia Carla da Hora, Elie Tabet, Christian Elias Badr, Bakhos Tannous

Institution: Massachusetts General Hospital

Language: English

Topic: Genomics, phytochemicals, and oxidative stress

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2993476486

Cites:

Cited by:

Related to: 10